NDC 65862-712 – Atazanavir Sulfate
Atazanavir Sulfate 200 mg/1 · Capsule · Oral
Product NDC65862-712
Product details
- Brand name
- Atazanavir Sulfate
- Generic name
- Atazanavir
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA204806
- Marketed since
- June 25, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Protease Inhibitor
Active ingredients
- Atazanavir Sulfate 200 mg/1
Uses, dosage, side effects and warnings for Atazanavir Sulfate →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 65862-712-03 | 3 BLISTER PACK in 1 CARTON (65862-712-03) / 10 CAPSULE in 1 BLISTER PACK (65862-712-10) | Jun 25, 2018 |
| 65862-712-05 | 500 CAPSULE in 1 BOTTLE (65862-712-05) | Jun 25, 2018 |
| 65862-712-18 | 180 CAPSULE in 1 BOTTLE (65862-712-18) | Jun 25, 2018 |
| 65862-712-60 | 60 CAPSULE in 1 BOTTLE (65862-712-60) | Jun 25, 2018 |
Other Atazanavir Sulfate products
- 65862-710 Atazanavir Sulfate 100 mg/1 · Capsule · Aurobindo Pharma Limited
- 65862-711 Atazanavir Sulfate 150 mg/1 · Capsule · Aurobindo Pharma Limited
- 65862-713 Atazanavir Sulfate 300 mg/1 · Capsule · Aurobindo Pharma Limited
- 0093-5526 Atazanavir Sulfate 150 mg/1 · Capsule · Teva Pharmaceuticals USA, Inc.
- 0093-5527 Atazanavir Sulfate 200 mg/1 · Capsule · Teva Pharmaceuticals USA, Inc.
- 0093-5528 Atazanavir Sulfate 300 mg/1 · Capsule · Teva Pharmaceuticals USA, Inc.